SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stephanie Mocilan who wrote ()5/16/1999 10:36:00 AM
From: Investor Dave  Read Replies (1) of 998
 
Hi all,

Saw a thread on Cephalon's sleep disorder drug on CNBC (provigil). They did not mention Cephalon, but showed label with Cephalon's name. They had an interview with a patient who seems to praise Provigil for giving her back her life and career. But, they also expresed concern about abuse of drug by busy people who try to scrimp on sleep. They talked about possibility of drug being prescribed off label to these people. I did not sense any negative vibes from the clip. Will this help or hurt the stock? I guess any positve PR is good for Cephelon. It is sinking back to lower stock price level again. Did anyone see this clip and have any opinions?

Dave.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext